These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 37850281)
1. [Effect of Fitofron on the persistence factors of opportunistic pathogens in urine isolated from patients with urinary tract infections]. Pashkova TM; Pashinina OA; Kuzmin MD; Kartashova OL Urologiia; 2023 Sep; (4):53-57. PubMed ID: 37850281 [TBL] [Abstract][Full Text] [Related]
2. [Effect of Prostanorm on the persistent potential of microorganisms isolated from patients with chronic bacterial prostatitis]. Pashinina OA; Kartashova OL; Pashkova TM; Kuzmin MD Urologiia; 2023 Sep; (4):69-74. PubMed ID: 37850284 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Antimicrobial Durability and Anti-Biofilm Effects in Urinary Catheters Against Kart D; Kustimur AS; Sağıroğlu M; Kalkancı A Balkan Med J; 2017 Dec; 34(6):546-552. PubMed ID: 29215338 [TBL] [Abstract][Full Text] [Related]
4. Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria. Zhanel GG; Pozdirca M; Golden AR; Lawrence CK; Zelenitsky S; Berry L; Schweizer F; Bay D; Adam H; Zhanel MA; Lagacé-Wiens P; Walkty A; Irfan N; Naber K; Lynch JP; Karlowsky JA Drugs; 2022 Apr; 82(5):533-557. PubMed ID: 35294769 [TBL] [Abstract][Full Text] [Related]
5. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. Farrell DJ; Morrissey I; De Rubeis D; Robbins M; Felmingham D J Infect; 2003 Feb; 46(2):94-100. PubMed ID: 12634070 [TBL] [Abstract][Full Text] [Related]
6. [Formation of microbial biofilms in causative agents of acute and chronic pyelonephritis]. Lagun LV; Atanasova IuV; Tapal'skiĭ DV Zh Mikrobiol Epidemiol Immunobiol; 2013; (3):18-23. PubMed ID: 24000589 [TBL] [Abstract][Full Text] [Related]
7. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757 [TBL] [Abstract][Full Text] [Related]
8. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754 [TBL] [Abstract][Full Text] [Related]
9. [Opportunistic microorganisms in urinary tract diseases]. Mironov AIu; Savitskaia KI; Vorob'ev AA Vestn Ross Akad Med Nauk; 2001; (2):7-11. PubMed ID: 11338508 [TBL] [Abstract][Full Text] [Related]
10. Virulence factors profile of drug-resistant Escherichia coli isolates from urinary tract infections in Punjab, Pakistan. Idress M; Mussarat U; Badshah Y; Qamar R; Bokhari H Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1533-7. PubMed ID: 20814711 [TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial susceptibilities of organisms isolated from patients with urinary tract infections in 2002]. Eta S; Kawahara M Jpn J Antibiot; 2006 Feb; 59(1):21-8. PubMed ID: 16673579 [TBL] [Abstract][Full Text] [Related]
12. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection. Akhter T; Baqai R; Aziz M Pak J Pharm Sci; 2010 Jan; 23(1):108-13. PubMed ID: 20067876 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial Resistance in Bacteria Causing Urinary Tract Infections. Salh KK Comb Chem High Throughput Screen; 2022; 25(7):1219-1229. PubMed ID: 34161207 [TBL] [Abstract][Full Text] [Related]
14. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). II. Background of patients]. Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F Jpn J Antibiot; 1996 May; 49(5):494-508. PubMed ID: 8752863 [TBL] [Abstract][Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F Jpn J Antibiot; 1996 May; 49(5):465-93. PubMed ID: 8752862 [TBL] [Abstract][Full Text] [Related]
16. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1985). II. Background of patients]. Kosakai N; Kumamoto Y; Sakai S; Hirose T; Okayama S; Shigeta S; Shiraiwa Y; Yoshida H; Miura Y; Ogata M Jpn J Antibiot; 1987 Dec; 40(12):2012-25. PubMed ID: 3129602 [TBL] [Abstract][Full Text] [Related]
17. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution]. Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333 [TBL] [Abstract][Full Text] [Related]
18. Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Matsumoto T; Hamasuna R; Ishikawa K; Takahashi S; Yasuda M; Hayami H; Tanaka K; Kiyota H; Muratani T; Monden K; Arakawa S; Yamamoto S Int J Antimicrob Agents; 2011 Mar; 37(3):210-8. PubMed ID: 21242062 [TBL] [Abstract][Full Text] [Related]
19. [Characteristics of the pathogenic potential of Escherichia coli isolated from patients with calculous pyelonephritis]. Pashkova TM; Morozova NV; Kuzmin MD; O KL; Popova LP Urologiia; 2021 Sep; (4):19-24. PubMed ID: 34486270 [TBL] [Abstract][Full Text] [Related]
20. The Cationic Antimicrobial Peptide Activity of Lysozyme Reduces Viable Rouchon CN; Harris J; Zubair-Nizami Z; Weinstein AJ; Roky M; Frank KL Antimicrob Agents Chemother; 2022 May; 66(5):e0233921. PubMed ID: 35446133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]